Top

Published in:

01-03-2010 | Original Research Article

Hospitalization for Severe Bacterial Infections in Children after Exposure to NSAIDs

A Prospective Adverse Drug Reaction Reporting Study

Authors: Sandrine Leroy, Elisabeth Marc, Françoise Bavoux, Jean-Marc Tréluyer, Dominique Gendrel, Gérard Bréart, Gérard Pons, Professor Martin Chalumeau

Published in: Clinical Drug Investigation | Issue 3/2010

Abstract

Background: NSAIDs are widely used to treat fever and pain in children, but their possible role in the progression of some bacterial infections is controversial.

Objective: This study was performed to analyse reported cases of severe bacterial infection associated with NSAID exposure in children admitted for this reason to a general paediatric department.

Methods: This study was based on the reporting system of hospital admissions for severe bacterial infections in children after NSAID exposure, and followed the recommendations of the European Guidelines of Pharmacovigilance for medicines used in a paediatric population. Data were prospectively collected and reported by active daily surveillance in the department from November 2002 to November 2005.

Results: Thirty-two cases of severe bacterial infections (cellulitis, soft tissue abscesses, parapneumonic empyema, necrotizing pneumonia, adenophlegmon [fever and a tender, warm and easily compressible neck mass] and lateral or retropharyngeal abscesses) were identified in children who had received NSAIDs, principally ibuprofen, in an exposure window of 15 days before the beginning of the signs of infection. Staphylococcus aureus, group A streptococci and Streptococcus pneumoniae were identified. Seven (22%) children required surgical treatment, and four (13%) were hospitalized in an intensive care unit. The frequency of hospitalization for severe bacterial infection as a possible adverse effect of NSAID use was 0.6% (95% CI 0.4, 0.9) of all admissions during the study period.

Conclusions: The frequency of severe bacterial infections after exposure to NSAIDs was elevated (one case per month) in the department studied. Further work is necessary to confirm these findings, given the potential for recruitment and protopathic biases in our study.

Autret-Leca E. A general overview of the use of ibuprofen in paediatrics. Int J Clin Pract Suppl 2003; 135: 9–12PubMed

Perrott DA, Piira T, Goodenough B, et al. Efficacy and safety of acetaminophen vs ibuprofen for treating children’s pain or fever: a meta-analysis. Arch Pediatr Adolesc Med 2004; 158: 521–6PubMedCrossRef

Goldman RD, Ko K, Linett LJ, et al. Antipyretic efficacy and safety of ibuprofen and acetaminophen in children. Ann Pharmacother 2004; 38: 146–50PubMedCrossRef

Leroy S, Mosca A, Landre-Peigne C, et al. Ibuprofen in childhood: evidence-based review of efficacy and safety. Arch Pediatr 2007; 14: 477–84PubMedCrossRef

Neutel CI, Pless RP. Ibuprofen use in children: a benefit or a risk? Ann Epidemiol 1997; 7: 437–9PubMedCrossRef

Ulinski T, Guigonis V, Dunan O, et al. Acute renal failure after treatment with non-steroidal anti-inflammatory drugs. Eur J Pediatr 2004; 163: 148–50PubMedCrossRef

Kahn LH, Styrt BA. Necrotizing soft tissue infections reported with nonsteroidal antiinflammatory drugs. Ann Pharmacother 1997; 31: 1034–9PubMed

Zerr DM, Alexander ER, Duchin JS, et al. A case-control study of necrotizing fasciitis during primary varicella. Pediatrics 1999; 103: 783–90PubMedCrossRef

Hamilton SM, Bayer CR, Stevens DL, et al. Muscle injury, vimentin expression, and nonsteroidal antiinflammatory drugs predispose to cryptic group A streptococcal necrotizing infection. J Infect Dis 2008; 198: 1692–8PubMedCrossRef

10.

Aronoff DM, Mulla ZD. Nonsteroidal antiinflammatory drugs and group A streptococcal infection [letter]. Emerg Infect Dis 2006; 12: 1291PubMedCrossRef

11.

Factor SH, Levine OS, Harrison LH, et al. Risk factors for pediatric invasive group A streptococcal disease. Emerg Infect Dis 2005; 11: 1062–6PubMedCrossRef

12.

Lesko SM, O’Brien KL, Schwartz B, et al. Invasive group A streptococcal infection and nonsteroidal antiinflammatory drug use among children with primary varicella. Pediatrics 2001; 107: 1108–15PubMedCrossRef

13.

Brogan TV, Nizet V, Waldhausen JH, et al. Group A streptococcal necrotizing fasciitis complicating primary varicella: a series of fourteen patients. Pediatr Infect Dis J 1995; 14: 588–94PubMedCrossRef

14.

Dubos F, Hue V, Grandbastien B, et al. Bacterial skin infections in children hospitalized with varicella: a possible negative impact of non-steroidal anti-inflammatory drugs? Acta Derm Venereol 2008; 88: 26–30PubMedCrossRef

15.

Ndiaye B. Étude des facteurs de risque de survenue des surinfections cutanées chez les enfants atteints de varicelle vus à l’hôpital. Institut de veille sanitaire [online]. Available from URL: http://wwwinvssantefr/publications/2008/varicelle/index.html [Accessed 2009 Nov 10]

16.

Bauvin I, Lacoste A, Bonamy C. Abcès rétro et parapharyngés de l’enfant: à propos d’une série de 31 cas [abstract]. Arch Pediatr 2006; 13: 874

17.

Revol P, Gleizal A, Kraft T, et al. Brain abscess and diffuse cervico-facial cellulitis: complication after mandibular third molar extraction. Rev Stomatol Chir Maxillofac 2003; 104: 285–9PubMed

18.

Audebert S, Vic P, Feuvrier Y, et al. Radiological quiz of the month. Arch Pediatr 2004; 11: 1472, 95-7PubMedCrossRef

19.

Byington CL, Spencer LY, Johnson TA, et al. An epidemio-logical investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin Infect Dis 2002; 34: 434–40PubMedCrossRef

20.

Lamagni TL, Neal S, Keshishian C, et al. Severe Streptococcus pyogenes infections, United Kingdom, 2003–2004. Emerg Infect Dis 2008; 14: 202–9PubMedCrossRef

21.

Horwitz RI, Feinstein AR. The problem of ‘protopathic bias’ in case-control studies. Am J Med 1980; 68: 255–8PubMedCrossRef

22.

Lesko SM, Mitchell AA. An assessment of the safety of pediatric ibuprofen: a practitioner-based randomized clinical trial. JAMA 1995; 273: 929–33PubMedCrossRef

23.

Mitchell AA, Lesko SM. When a randomised controlled trial is needed to assess drug safety: the case of paediatric ibuprofen. Drug Saf 1995; 13: 15–24PubMedCrossRef

24.

Lesko SM, Mitchell AA. Renal function after short-term ibuprofen use in infants and children. Pediatrics 1997; 100: 954–7PubMedCrossRef

25.

Committee for Medical Products for Human Use. Guideline on conduct of pharmacovigilance for medicines used by the paediatric population. European Medicines Agency 2005 [online]. Available from URL: http://www.emea.europa.eu [Accessed 2009 Nov 10]

26.

Choo PW, Donahue JG, Platt R. Ibuprofen and skin and soft tissue superinfections in children with varicella. Ann Epidemiol 1997; 7: 440–5PubMedCrossRef

27.

Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239–45PubMedCrossRef

28.

Stevens DL. Could nonsteroidal antiinflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome? Clin Infect Dis 1995; 21: 977–80PubMedCrossRef

29.

Bensouda L, Michaud L, Jonville-Bera APJ, et al. Is the risk of upper gastrointestinal bleeding increased with NSAID used as analgesic, in children: a case crossover study. Drug Saf 2004; 27: 919–20

Title: Hospitalization for Severe Bacterial Infections in Children after Exposure to NSAIDs
A Prospective Adverse Drug Reaction Reporting Study
Authors: Sandrine Leroy
Elisabeth Marc
Françoise Bavoux
Jean-Marc Tréluyer
Dominique Gendrel
Gérard Bréart
Gérard Pons
Professor Martin Chalumeau
Publication date: 01-03-2010
Publisher: Springer International Publishing
Published in: Clinical Drug Investigation / Issue 3/2010
Print ISSN: 1173-2563
Electronic ISSN: 1179-1918
DOI: https://doi.org/10.2165/11532890-000000000-00000

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Hospitalization for Severe Bacterial Infections in Children after Exposure to NSAIDs

A Prospective Adverse Drug Reaction Reporting Study

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2010

Predictors of Early Worsening after Switch to Aripiprazole

The Burden of Disrupting Gastro-Oesophageal Reflux Disease

Does Functional Outcome in Acute Ischaemic Stroke Patients Correlate with the Amount of Free-Radical Scavenger Treatment?

Incorporating BCNU Wafers into Malignant Glioma Treatment

Atorvastatin-Induced Prolonged Cholestasis with Bile Duct Damage

Efficacy and Safety of Ezetimibe for Japanese Patients with Dyslipidaemia